ArticleParasites & vectors2025
The genomic diversity of arthropod-specific viruses reinforces the continental distribution pattern of Aedes aegypti.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAedes aegypti is the primary vector of arboviruses worldwide, including dengue, Zika, chikungunya, and yellow fever. It is believed to have originated in Africa and migrated to the Americas during the sixteenth and seventeenth centuries, subsequently spreading to Asia and Oceania between the nineteenth and twentieth centuries. These mosquitoes harbor insect-specific viruses (ISVs), which represent the majority of their core virome. Phasivirus phasiense (PCLV), cell-fusing agent virus (CFAV), and Aedes anphevirus (AeAV) stand out for their global distribution in vectors. Within this framework, this study aims to evaluate whether ISVs can provide insights into the continental dispersal history of Ae. aegypti.
methodsA total of 96 complete sequences from three ISVs (CFAV, AeAV, and PCLV) were analyzed. These were obtained from wild Ae. aegypti collected across four regions: the Americas (45), Asia (38), Africa (12), and Oceania (1), as well as from laboratory colonies originally derived from wild mosquitoes. Of the 45 sequences from the Americas, 12 were newly assembled for this study from mosquito samples collected in Ibagué, Colombia in 2021 (4 per ISV). To reconstruct the vector's dispersal history and compare evolutionary patterns between viruses with and without evidence of recombination, multiple methodological approaches were used: (1) phylogenetic analyses with BEAST1 to estimate divergence times, (2) statistical tests for recombination (Φ-test), (3) recombination network construction using SplitsTree and RDP, and (4) principal component analysis (PCA) to evaluate population structure.
resultsThe analysis of three ISVs in global Ae. aegypti populations allowed for the inference of the vector's historical dispersal. The results revealed: (1) genetically structured diversity patterns associated with geography, (2) evidence of recombination in PCLV, but not in AeAV and CFAV, and (3) contrasting temporal estimates suggesting multiple introductions into the Americas between the seventeenth and nineteenth centuries, as well as recent dispersal into Oceania.
conclusionsISVs are promising tools for studying the dispersal and evolution of Ae. aegypti, although their viral dynamics can influence their effectiveness as evolutionary markers. CFAV, with recombination evidence, reflects strong connectivity among populations. AeAV, despite lacking recombination but high variability, provides accurate insights into recent dispersal. PCLV, with low diversity and regional recombination, is useful for analyzing local population structures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.